It seems like whenever another study is released, the vaccine effectiveness is revised upwards.
Does it?
There are the initial phase three trials
Pfizer - 95%. Moderna - 94.5%. Oxford/AZ - 70% / 79% (done two phase III trials). Sputnik V - 91.6%. J&J (single dose) - 66% etc.
All the phase three trials showed 100% efficacy in stopping death.
Then when have these figures been revised up?
The first published, peer-reviewed, real-world study came from Israel. They only use Pfizer and studies there have shown it's in the mid 90s in terms of efficacy (
https://www.bmj.com/content/372/bmj.n567). That's about what the trial said.
Then there's that study above from the US which tested both Pfizer and Moderna and showed 90%+ efficacy in terms of stopping asymptomatic infection (
https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7013e3-H.pdf). Again about what the trials said.
Lots of the stuff is just preliminary data analysis. That's very useful, but it is more probable there are errors/ other factors involved.
Some things we see really can't be compared to the trials too. This AZ study from Scotland looks at something quite different and doesn't follow the trial's dosing regimen. (
https://www.astrazeneca.com/media-c...strates-94-reduction-in-hospitalisations.html). Still, the data it presents is incredibly positive.